The results showed that the expression of KLF14 in sepsis patients was significantly higher than that in the control group, and GEO data indicated that KLF14 was mainly enriched in type 2 diabetes and sucrose signaling pathways, identifying a correlation between KLF14 and glucose metabolism pathways. The gene discussed is KLF14; the disease is type 2 diabetes mellitus.